Seres Therapeutics, Inc. (MCRB): Long-Term Debt
Older than the company's other figures. The latest Long-Term Debt is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$110.00M
As of 2023-12-31
+63.9%
3-year compound annual growth
| Period ended | Long-Term Debt | Change YoY | Source filing |
|---|---|---|---|
| 2023-12-31 | $110.00M | +120.0% | 2024-03-05, Balance as of period end |
| 2022-12-31 | $50.00M | +107.9% | 2023-03-07, Balance as of period end |
| 2021-12-31 | $24.05M | -3.8% | 2022-03-01, Balance as of period end |
| 2020-12-31 | $25.00M | 0.0% | 2021-03-02, Balance as of period end |
| 2019-12-31 | $25.00M | n/a | 2020-03-02, Balance as of period end |